Medical Animation Imaging - 3d Graphics Medical

Earlier, Individualized Treatment Of Thyroid Cancer Enabled By Molecular Imaging
In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.

Fat Tissue Is Sensitive To Irradiation
Researchers led by Dr. Béatrice Cousin at Institut Louis Bugnard found that irradiation damages fat tissue. They report their findings in the January 2009 issue of The American Journal of Pathology. Radiation therapy directed at cancer management also damages normal tissues.

Adipose Stem & Regenerative Cell Clinical Study Underway For Treatment Of Chronic Radiation Injury
Cytori (NASDAQ: CYTX) announced that the first patient was enrolled in an investigator-initiated study using adipose-derived stem and regenerative cells to treat the chronic effects of radiation-induced local tissue injury. The 30-patient study is being conducted independently by Nagasaki University Hospital in Japan. Cytori's Celution® 800 System is being used to process and extract patients' own adipose tissue-derived stem and regenerative cells.

People More Likely To Attend Cancer Screening Close To Christmas And Birthdays
Cancer screening programmes could increase attendance by inviting people for screening close to birthdays or other annual milestones such as Christmas and the New Year, finds a study in the Christmas issue published on bmj.com. Colorectal cancer (bowel cancer) is the third most common cancer in the UK and the second leading cause of cancer deaths in Europe and the US. But despite the promotion of screening programmes in many western countries, attendance is generally low.

Change Determinants In PSA Over Time - Its Association With Recurrence After External Beam Radiation Therapy For Prostate Cancer In 5 Large Cohorts
UroToday.com - In the November 1, 2008 issue of International Journal of Radiation Oncology, Biology, Physics, Dr. Cécile Proust-Lima and colleagues presented a linear mixed model to construct patient PSA profiles after radiotherapy (XRT) for prostate cancer (CaP). The included XRT data from 5 patient cohorts where men with CaP were treated for clinically localized disease.

Breakthrough In Cancer Therapy Using Radiation - Linac-MR System Operational With MR Imaging During 6 MV Irradiation
Fallone from the Cross Cancer Institute (CCI) , Alberta Cancer Board of the Alberta Health Services (Edmonton, AB) reports that CCI medical physicists have produced the first image from a linac-MR hybrid system on December 10, 2008. The MR images during 6 MV irradiation do not show significant distortions and are very similar to those obtained prior to irradiation. There is a small difference in signal-to-noise between images. MR image is obtained during the irradiation from a 6 MV linac.

SNM's Mid-Winter Educational Symposium Offers In-Depth Learning For Nuclear Medicine And Molecular Imaging Professionals
SNM will hold its annual Mid-Winter Educational Symposium February 5-8, 2009 at the Hilton Clearwater in Clearwater, FL. This year SNM, the American College of Nuclear Physicians (ACNP) and the American College of Nuclear Medicine (ACNM) unite to create a fused meeting, offering attendees the opportunity to earn up to 31.25 credits. "The strength and range of the education content that will be presented at the mid-winter meeting are exceptional," said Robert W. Atcher, Ph.D., M.B.

Improved Hearing Preservation Following Lower-Dose Fractionated Stereotactic Radiotherapy
Researchers at Thomas Jefferson University have found that a lower dose of fractionated stereotactic radiotherapy for acoustic neuromas results in better hearing preservation and has the same tumor local control rate as a higher dose of therapy. The study appeared online in the International Journal of Radiation Oncology*Biology*Physics. "We previously had not determined the optimal dose of fractionated stereotactic radiotherapy for acoustic neuromas," said David W.

Journal Of Nuclear Medicine Premiers New, Full-Color Design
Beginning with the January 2009 issue, The Journal of Nuclear Medicine - SNM's flagship publication - will be printed in full color. "This change to the publication allows the generous use of color for highlighting and enhancing the structure and organization of research reports," said Heinrich R. Schelbert, M.D., editor in chief of The Journal of Nuclear Medicine.

Prostate Cancer Patient From Warrington Becomes First In UK To Be Treated Using RapidArc™ Radiotherapy From Varian Medical Systems
65-year-old grandfather of six, Graham McCormack has become the first cancer patient in the UK to be treated using RapidArc radiotherapy technology from Varian Medical Systems . Mr McCormack, from Warrington in Cheshire, received the fast and efficient treatment at Clatterbridge centre for Oncology in the Wirral, the first UK cancer centre to introduce the revolutionary new treatment technique.

SNM's Mid-Winter Educational Symposium For Nuclear Medicine And Molecular Imaging Professionals Feb. 5-8, 2009, Clearwater, Fla.
SNM will hold its annual Mid-Winter Educational Symposium February 5-8, 2009 at the Hilton Clearwater in Clearwater, FL. This year SNM, the American College of Nuclear Physicians (ACNP) and the American College of Nuclear Medicine (ACNM) unite to create a fused meeting, offering attendees the opportunity to earn up to 31.25 credits. "The strength and range of the education content that will be presented at the mid-winter meeting are exceptional," said Robert W. Atcher, Ph.D., M.

Parion Sciences Receives NIH Biodefense Grant To Study Novel Methods For Mitigating Radiation-Induced Lung Injury
Parion Sciences, Inc., a privately-held, development-stage pharmaceutical company dedicated to treating diseases resulting from the failure of the body's mucosal defenses, today announced that the National Institutes of Health (NIH) have awarded the company a biodefense grant in excess of $850,000.

Refining Cancer Treatments To Reduce Potential Nerve Damage
While radiation treatments deliver precise doses of high-energy X-rays to stop cancer cells from spreading or to shrink tumors, oncologists have become increasingly concerned about inadvertent exposures during head and neck cancer treatments to nerves responsible for upper body mobility. To reduce the possibility of permanent nerve damage, UC Davis Cancer Center researchers have taken the lead in establishing new treatment guidelines for physicians nationwide.

Computer-Aided Mammography Finds More Cancer, More False Positives
Computer programs designed to help radiologists could identify more cases of breast cancer, but they might also increase the number of false-positive results, which can lead to biopsies in healthy women, according to a recent systematic review. Using computer-aided detection (CAD) mammography, "you do catch some cases that would have been missed if the mammogram had been read only by a single radiologist," said review author Meredith Noble, a research analyst at ECRI Institute.

Combining Radiotherapy With Hormone Treatment Halves Prostate Cancer Mortality
In patients with locally advanced or high-risk prostate cancer, combining prostate radiotherapy with the conventional endocrine (hormone) treatment halves mortality. Thus endocrine treatment plus radiotherapy should be the new standard. These are the conclusions of authors on an Article published Online first and in an upcoming edition of The Lancet, written by Professor Anders Widmark, Department of Radiation Sciences, Oncology, Umeå University, Sweden, and colleagues.